Global Breast-Conserving Surgery Market Growth (Status and Outlook) 2025-2031

The global Breast-Conserving Surgery market size is predicted to grow from US$ 1737 million in 2025 to US$ 2675 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

Breast-Conserving Surgery (BCS), also known as a lumpectomy or partial mastectomy, is a surgical procedure aimed at removing cancerous or abnormal tissue from the breast while preserving as much healthy breast tissue as possible. This approach is often used in the treatment of early-stage breast cancer and is typically followed by radiation therapy to reduce the risk of recurrence. The goal of BCS is to achieve effective cancer control while maintaining the natural appearance and function of the breast.

Market Drivers:

The Breast-Conserving Surgery (BCS) market is driven by the rising prevalence of breast cancer worldwide, which has heightened the demand for minimally invasive and tissue-sparing surgical options. Advances in medical technology, such as imaging-guided surgery and intraoperative margin assessment tools, have improved the precision and outcomes of BCS, encouraging adoption. Additionally, increased awareness of early breast cancer detection through screening programs and patient preference for cosmetic outcomes and quality of life post-surgery further propel market growth.

Market Challenges:

The market faces challenges such as limited access to advanced surgical facilities in low- and middle-income countries, where healthcare infrastructure may not support complex procedures. Furthermore, the high cost of equipment and techniques associated with BCS can be a barrier for both providers and patients. Another significant issue is the risk of incomplete tumor excision, which may lead to recurrence and necessitate additional treatments, impacting patient confidence and market adoption.

Global key players of breast-conserving surgery include Hologic, BD, Danaher, Carl Zeiss Meditech, Merit Medical, etc. The top five players hold a share about 42%. Service providers are mainly located in North America and Europe, they occupied for a share over 47%. The largest market is North America, holds a share about 43%, followed by Europe and Asia-Pacific, with around 26% and 25% market share respectively.

LPI (LP Information)' newest research report, the “Breast-Conserving Surgery Industry Forecast” looks at past sales and reviews total world Breast-Conserving Surgery sales in 2024, providing a comprehensive analysis by region and market sector of projected Breast-Conserving Surgery sales for 2025 through 2031. With Breast-Conserving Surgery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast-Conserving Surgery industry.

This Insight Report provides a comprehensive analysis of the global Breast-Conserving Surgery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Breast-Conserving Surgery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breast-Conserving Surgery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast-Conserving Surgery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast-Conserving Surgery.

This report presents a comprehensive overview, market shares, and growth opportunities of Breast-Conserving Surgery market by product type, application, key players and key regions and countries.

Segmentation by Type:
Lumpectomy Systems
Lumpectomy Surgical Tools

Segmentation by Application:
Hospitals
Ambulatory Surgical Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Hologic
BD
Danaher
Carl Zeiss Meditech
Merit Medical
Argon Medical Devices
IceCure
Endomagnetics
SOMATEX Medical
Ranfac
STERYLAB
SamanTree Medical
Perimeter Medical Imaging AI
Dilon Technologies
XEOS Medical

Please note: The report will take approximately 2 business days to prepare and deliver.